Invasive meningococcal disease: Impact of short course therapy. A DOOR/RADAR study

Area of Science:

• Infectious Diseases
• Clinical Microbiology
• Pharmacotherapy

Background:

• Invasive meningococcal disease (IMD) is a serious bacterial infection.
• Optimal antibiotic treatment duration for IMD is not definitively established.
• Current treatment guidelines lack clear recommendations on the shortest effective antibiotic course for IMD.

Purpose of the Study:

• To compare the efficacy and safety of a 4-day antibiotic regimen versus a 7-day regimen for treating invasive meningococcal disease.
• To evaluate clinical outcomes, including relapse rates, case fatality, and sequelae, between the two treatment durations.
• To assess patient-reported outcomes using the Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR) methodologies.

Main Methods:

• A comparative study involving 263 patients treated with a 4-day antibiotic course and 264 patients previously treated with a 7-day course.
• Utilized Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR) for outcome assessment.
• Analyzed clinical characteristics, laboratory findings, complications, case fatality rates, and neurological/cutaneous sequelae.

Main Results:

• No relapses were observed in either the 4-day or 7-day treatment groups.
• There were no statistically significant differences in case fatality rates (7% vs. 6%) or neurological/cutaneous sequelae between the groups.
• The 4-day regimen demonstrated a significantly higher probability (80.4%) of achieving a better outcome compared to the 7-day regimen.

Conclusions:

• A 4-day course of antibiotic therapy is a safe and effective treatment for invasive meningococcal disease.
• Shorter antibiotic durations can be utilized without compromising patient outcomes or increasing the risk of relapse.
• These findings support the potential for de-escalation of antibiotic therapy duration in IMD management.